ReviewInternational journal of molecular sciences2022

Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer.

Caterina Gianni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.